1. Home
  2. ATHE vs AIFU Comparison

ATHE vs AIFU Comparison

Compare ATHE & AIFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • AIFU
  • Stock Information
  • Founded
  • ATHE 1997
  • AIFU 1998
  • Country
  • ATHE Australia
  • AIFU China
  • Employees
  • ATHE N/A
  • AIFU N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • AIFU
  • Sector
  • ATHE Health Care
  • AIFU
  • Exchange
  • ATHE Nasdaq
  • AIFU NYSE
  • Market Cap
  • ATHE 21.4M
  • AIFU 21.4M
  • IPO Year
  • ATHE N/A
  • AIFU 2007
  • Fundamental
  • Price
  • ATHE $4.75
  • AIFU $0.38
  • Analyst Decision
  • ATHE Strong Buy
  • AIFU
  • Analyst Count
  • ATHE 2
  • AIFU 0
  • Target Price
  • ATHE $8.00
  • AIFU N/A
  • AVG Volume (30 Days)
  • ATHE 1.3M
  • AIFU 1.4M
  • Earning Date
  • ATHE 02-15-2025
  • AIFU 03-19-2025
  • Dividend Yield
  • ATHE N/A
  • AIFU N/A
  • EPS Growth
  • ATHE N/A
  • AIFU N/A
  • EPS
  • ATHE N/A
  • AIFU 0.38
  • Revenue
  • ATHE $2,681,669.00
  • AIFU $324,923,970.00
  • Revenue This Year
  • ATHE N/A
  • AIFU N/A
  • Revenue Next Year
  • ATHE N/A
  • AIFU $11.81
  • P/E Ratio
  • ATHE N/A
  • AIFU $1.00
  • Revenue Growth
  • ATHE 2.63
  • AIFU N/A
  • 52 Week Low
  • ATHE $1.00
  • AIFU $0.33
  • 52 Week High
  • ATHE $5.87
  • AIFU $6.59
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 75.45
  • AIFU N/A
  • Support Level
  • ATHE $2.76
  • AIFU N/A
  • Resistance Level
  • ATHE $5.14
  • AIFU N/A
  • Average True Range (ATR)
  • ATHE 0.42
  • AIFU 0.00
  • MACD
  • ATHE 0.15
  • AIFU 0.00
  • Stochastic Oscillator
  • ATHE 71.14
  • AIFU 0.00

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS

AIX Inc is a technology-driven financial services provider company in China. It is an intelligent platform that creates a supportive and collaborative environment and provides solutions that integrate technology, products, services, operations, capital, and professional support for individual agents and sales organizations. The group uses technology, AI, and data-driven insights, pioneering the financial services that are delivered, its transformation, and empowering industry development. It connects customers with financial institutions, investment opportunities, and service providers, offering insurance, wealth management, and other value-added services.

Share on Social Networks: